Encompass Health Corp. (NYSE: EHC) today announced it will participate in the BofA Securities Virtual Health Care…
Category: Insights
175 Organizations Receive $3.5M in COVID-19 Relief Funding from Blue Cross and Blue Shield of Illinois
Blue Cross and Blue Shield of Illinois (BCBSIL) today is announcing that an expanded pool of 175 non-profit organizations…
Windtree Therapeutics Reports Fourth Quarter and Year End 2020 Financial Results and Provides Key Business Updates
Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology and medical device company focused on advancing multiple late-stage…
Milestone Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Clinical and Corporate Update
Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines,…
Ascletis Announces Investment Escalation in R&D of Cancer Lipid Metabolism and Oral Checkpoint Inhibitors
Proposed Initiation of a Pivotal Phase II Trial of ASC40 in Combination with Bevacizumab in Chinese…
$ 27.43 Billion Growth in Global Healthcare Revenue Cycle Management (RCM) Software Market 2021-2025
The healthcare revenue cycle management (RCM) software market is expected to grow by USD 27.43 billion during 2021-2025,…
Nutraceutical Ingredients Market Size to Reach USD 167.3 Million by 2026 at CAGR 4.0% – Valuates Reports
The Nutraceutical Ingredients Market is Segmented by Type (Amino Acids, Peptides and Proteins, Lutein, Zeaxanthin, Minerals, Polyphenols and Flavonoids, Probiotics,…
$ 157 Billion Growth in Global Activewear Apparel Market 2020-2024| Technavio
The global activewear apparel market is set to grow by USD 157.1 billion, progressing at a CAGR of…
Relmada Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2020 Financial Results
Relmada Therapeutics, Inc. (Nasdaq: RLMD), a late-stage biotechnology company addressing diseases of the central nervous system (CNS),…
CASI Pharmaceuticals Announces Proposed Public Offering Of Common Stock
CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and…